[1,7]naphthyridines as pde4 inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 471/04 (2006.01) A61K 31/4375 (2006.01) A61P 29/00 (2006.01)

Patent

CA 2505405

Compounds of Formula (I) in free or salt form, wherein R1, R2 and R3 have the meanings as indicated in the specification, are useful for treating conditions mediated by of phosphodiesterase type 4 or the down-regulation or inhibition of TNF-.alpha. release, particularly obstructive or inflammatory airways diseases. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.

L'invention concerne des composés de formule générale (I) sous forme libre ou sous forme de sel, dans laquelle R?1¿, R?2¿ et R?3¿ ont la signification indiquée dans la description, utiles pour le traitement d'états dont la médiation est assurée par la phosphodiestérase de type 4 ou par la diminution ou l'inhibition de libération de TNF-.alpha., en particulier les maladies respiratoires obstructives ou inflammatoires. L'invention concerne également des compositions pharmaceutiques contenant lesdits composés ainsi que des procédés de préparation de ces derniers.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

[1,7]naphthyridines as pde4 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with [1,7]naphthyridines as pde4 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and [1,7]naphthyridines as pde4 inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1434306

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.